232 TRAIL RECEPTOR I POLYMORPHISMS C626G AND A638C ARE ASSOCIATED WITH AN INCREASED RISK FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN HCV-INFECTED PATIENTS

Bibliographic Details
Title: 232 TRAIL RECEPTOR I POLYMORPHISMS C626G AND A638C ARE ASSOCIATED WITH AN INCREASED RISK FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN HCV-INFECTED PATIENTS
Authors: Körner, C., Riesner, K., Krämer, B., Eisenhardt, M., Müller, T., Berg, T., Sauerbruch, T., Nattermann, J., Spengler, U., Nischalke, H.D.
Source: In Journal of Hepatology March 2011 54 Supplement 1:S96-S96
Database: ScienceDirect
More Details
ISSN:01688278
DOI:10.1016/S0168-8278(11)60234-1
Published in:Journal of Hepatology
Language:English